🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Come join us!

Dr. Steven Rosenberg delivered a terrific lecture today in acceptance of the AACR Award for Lifetime Achievement in Cancer Research. So well deserved and a testament to his remarkable career—congratulations! #AACR24 @NCIResearchCtr @NCI_CCR_SB spr.ly/6010wPZbC

Congratulations to the recipient of the Cancer Immunology Research Award for Outstanding Journal Article, Steven A. Rosenberg, for work on TCR–engineered T cells targeting mutant p53. bit.ly/4cUnsIw @tellkrish Franklowery Noam Stephanie L Goff, MD, FACS Anup Parikh, MD #AACR24 AACR

Not on the Twitter/X (that I know of) but started with key work by Parisa Malekzadeh #surgeonscientist and Drew Deniger. Building a TCR library that we can (hopefully) apply to so many people with advanced cancer!

Congratulations to all, but especially my boss, colleague, and mentor, Steven A. Rosenberg! Richly deserved and so incredibly happy for him @NCI_CCR_SB

Complex technology and immunology discussed wonderfully. Unlocking the mysteries of the T cell, even if society still can’t completely figure out hybrid conferences 😂

Expanding our understanding of neoantigens outside canonical reading frames. Excellent work analyzing mutated proteins in alternate RF and fusions as T cell targets. Strong work!

Fantastic choice!

#SITC24 Science Preview: Join Stephanie L Goff, MD, FACS National Cancer Institute, Marco Ruella Penn Medicine and Chrystal Paulos Winship Cancer Institute of Emory University to optimize the efficacy of T-cell administration in cancer treatment. View session details: ow.ly/jOBS50SaNC0

In this article, we describe tumor reduction after clinical application of personalized gene-engineered TCR cell therapy, from discovering rare clonotypes recognizing tumor-specific non-synonymous mutations, through cGMP manufacturing of retroviral supernatant and autologous PBL

Congratulations, Samira!! Samira Sadowski

The melanoma community is mourning the loss of a giant with the passing of Dr. Jeffrey Weber. His passion will live on in his work and in the many, many people he inspired to search for an end to cancer. Forever a member of the @NCI_CCR_SB family, may his loved ones find peace.

I can’t imagine going through that year without these two guys. And the support of our faculty and nurses. Thankful for the patients that taught me how to be a better doctor and finding my passion for cancer research.

I remember that day! I forgot it was picture day :) such great memories of Surgery Branch Tea Talks, with sludgy coffee, but getting to hear about everyone’s vacations or hobbies before diving into really interesting science.

An eye-opening talk by a fantastic educator! Thank you, Dr. Campbell, for sharing your passion with us. NIH Clinical Center

A little bit of #SITC24. On the tail end of four days in Houston. @NCI_CCR_SB #TIL for melanoma and more! Photo courtesy of the long arms of Aaron Dinerman, MD Alex Gustafson

"This is where we are now", Stephanie L. Goff and her evolving therapeutic landscape of metastatic melanoma #bridge2024 Paolo A. Ascierto

Always an inspiration to hear Dr Stephanie Goff present on #TILs. We need to stop thinking about this as palliative therapy! TILs have the potential to CURE- complete responders from National Cancer Institute with 10 year melanoma-specific survival of 96%. Unmodified TILs are just a starting

Congratulations, Fran! Richly deserved!

It was a happy task, being asked to reflect on the contributions of the Branch. Humbly standing on the shoulders of giants, creating the medicines of tomorrow. TIL immunotherapy comes of age: a journey of development in the Surgery Branch, NCI jitc.bmj.com/content/13/4/e…